| Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force JFP Bridges, AB Hauber, D Marshall, A Lloyd, LA Prosser, DA Regier, ... Value in health 14 (4), 403-413, 2011 | 1681 | 2011 |
| Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force FR Johnson, E Lancsar, D Marshall, V Kilambi, A Mühlbacher, DA Regier, ... Value in health 16 (1), 3-13, 2013 | 1591 | 2013 |
| Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force AB Hauber, JM González, CGM Groothuis-Oudshoorn, T Prior, ... Value in health 19 (4), 300-315, 2016 | 1017 | 2016 |
| Globalization and healthcare: understanding health and medical tourism PM Carrera, JFP Bridges Expert review of pharmacoeconomics & outcomes research 6 (4), 447-454, 2006 | 747 | 2006 |
| Conjoint analysis applications in health—how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008 D Marshall, JFP Bridges, B Hauber, R Cameron, L Donnalley, K Fyie, ... The Patient: Patient-Centered Outcomes Research 3, 249-256, 2010 | 350 | 2010 |
| Patient-based health technology assessment: a vision of the future JFP Bridges, C Jones International journal of technology assessment in health care 23 (1), 30-35, 2007 | 233 | 2007 |
| Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics JF Bridges Applied health economics and health policy 2 (4), 213-224, 2003 | 230 | 2003 |
| Using best–worst scaling to investigate preferences in health care KL Cheung, BFM Wijnen, IL Hollin, EM Janssen, JF Bridges, SMAA Evers, ... Pharmacoeconomics 34, 1195-1209, 2016 | 219 | 2016 |
| Understanding consumers’ preferences and decision to enrol in community-based health insurance in rural West Africa M De Allegri, M Sanon, J Bridges, R Sauerborn Health policy 76 (1), 58-71, 2006 | 187 | 2006 |
| Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982–2007 JFP Bridges, ET Kinter, L Kidane, RR Heinzen, C McCormick The Patient: Patient-Centered Outcomes Research 1, 273-282, 2008 | 165 | 2008 |
| Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis JFP Bridges, AF Mohamed, HW Finnern, A Woehl, AB Hauber Lung Cancer 77 (1), 224-231, 2012 | 151 | 2012 |
| Determinants of demand for total hip and knee arthroplasty: a systematic literature review REM Mota, R Tarricone, O Ciani, JFP Bridges, M Drummond BMC health services research 12, 1-18, 2012 | 144 | 2012 |
| Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure G Nichol, P Kaul, E Huszti, JFP Bridges Annals of internal medicine 141 (5), 343-351, 2004 | 132 | 2004 |
| Group decision making with the analytic hierarchy process in benefit-risk assessment: a tutorial JM Hummel, JFP Bridges, MJ IJzerman The Patient-Patient-Centered Outcomes Research 7, 129-140, 2014 | 129 | 2014 |
| Patient preferences for the treatment of type 2 diabetes: a scoping review SM Joy, E Little, NM Maruthur, TS Purnell, JFP Bridges Pharmacoeconomics 31, 877-892, 2013 | 128 | 2013 |
| Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability? EM Janssen, DA Marshall, AB Hauber, JFP Bridges Expert review of pharmacoeconomics & outcomes research 17 (6), 531-542, 2017 | 121 | 2017 |
| Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomized controlled trials JM Cloyd, V Heh, TM Pawlik, A Ejaz, M Dillhoff, A Tsung, T Williams, ... Journal of clinical medicine 9 (4), 1129, 2020 | 120 | 2020 |
| A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy HL Peay, I Hollin, R Fischer, JFP Bridges Clinical therapeutics 36 (5), 624-637, 2014 | 116 | 2014 |
| Older adults’ views and communication preferences about cancer screening cessation NL Schoenborn, K Lee, CE Pollack, K Armacost, SM Dy, JFP Bridges, ... JAMA internal medicine 177 (8), 1121-1128, 2017 | 115 | 2017 |
| Using latent class analysis to model preference heterogeneity in health: a systematic review M Zhou, WM Thayer, JFP Bridges Pharmacoeconomics 36, 175-187, 2018 | 113 | 2018 |
Ellen M. JanssenJohnson & JohnsonVerified email at its.jnj.com
